Business Description
HLB Science Inc
ISIN : KR7343090007
Share Class Description:
XKRX:343090: Ordinary SharesCompare
Compare
Traded in other countries / regions
343090.Korea IPO Date
2020-04-24Description
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.75 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.68 | |||||
| Debt-to-EBITDA | -0.7 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.82 | |||||
| 9-Day RSI | 67.76 | |||||
| 14-Day RSI | 60.48 | |||||
| 6-1 Month Momentum % | -15.52 | |||||
| 12-1 Month Momentum % | 18.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | |||||
| Quick Ratio | 6.1 | |||||
| Cash Ratio | 5.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -61.02 | |||||
| ROIC % | -47.81 | |||||
| ROC (Joel Greenblatt) % | -852.19 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 20.48 | |||||
| Price-to-Tangible-Book | 26.8 | |||||
| EV-to-EBIT | -18.59 | |||||
| EV-to-EBITDA | -21.59 | |||||
| EV-to-FCF | -10.34 | |||||
| Price-to-Net-Current-Asset-Value | 41.69 | |||||
| Price-to-Net-Cash | 46.32 | |||||
| Earnings Yield (Greenblatt) % | -5.38 | |||||
| FCF Yield % | -8.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HLB Science Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | |||
| EPS (TTM) (â‚©) | -205 | ||
| Beta | 1.24 | ||
| Volatility % | 112.95 | ||
| 14-Day RSI | 60.48 | ||
| 14-Day ATR (â‚©) | 160.945359 | ||
| 20-Day SMA (â‚©) | 1917.9 | ||
| 12-1 Month Momentum % | 18.19 | ||
| 52-Week Range (â‚©) | 1531 - 6600 | ||
| Shares Outstanding (Mil) | 17.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HLB Science Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HLB Science Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
HLB Science Inc Frequently Asked Questions
What is HLB Science Inc(XKRX:343090)'s stock price today?
The current price of XKRX:343090 is â‚©2035.00. The 52 week high of XKRX:343090 is â‚©6600.00 and 52 week low is â‚©1531.00.
When is next earnings date of HLB Science Inc(XKRX:343090)?
The next earnings date of HLB Science Inc(XKRX:343090) is .
Does HLB Science Inc(XKRX:343090) pay dividends? If so, how much?
HLB Science Inc(XKRX:343090) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers